Harrow's stock dropped about 20% after missing its first-half revenue targets, yet it remains a cautious Buy. The company’s full-year outlook requires strong performance in the second half, with Q3 and Q4 needing record revenues and positive EBITDA. Positive developments include new payer coverage for VEVYE, improved pricing for IHEEZO, and the strategic acquisition of TYRVAYA. The investment thesis hinges on Q3 results showing over $100 million in revenue and positive EBITDA to justify continued confidence.
Harrow's recent performance and outlook provide context for health sector market data. For readers following health stocks, here is Pluang's market snapshot as of Oct 08, 2026 18:43 WIB: out of 128 priced health-sector US stocks, 29 rose and 91 fell. Notable movers include WGS at USD 67.00 with a 1-day change of -2.23%, ROIV at USD 34.75 down 2.20%, and RXRX at USD 4.18 down 2.11%, with RXRX showing 95% sell order activity on Pluang.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
